AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiprime M 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimiprime M 0.5mg/500mg Tablet

Combiflex DM 0.5mg/500mg tablets are classified as antidiabetic agents, a dual-medication formulation for adult type 2 diabetes management. This medication regulates blood glucose levels. Administer Combiflex DM 0.5mg/500mg tablets with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication as prescribed, even with well-managed blood sugar; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction to Combiflex DM 0.5mg/500mg tablets is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, trembling—and implement appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests (evaluating blood cell counts and liver function) may be recommended by your doctor.

Uses of Glimiprime M 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiprime M 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimiprime M 0.5mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimiprime M 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiprime M 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimiprime M 0.5mg/500mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Glimiprime M 0.5mg/500mg Tablet works:

Glimiprime M 0.5mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiprime M 0.5mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiprime M 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimiprime M 0.5mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiprime M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimiprime M 0.5mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiprime M 0.5mg/500mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is advisable. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimiprime M 0.5mg/500mg Tablet :

Should you forget to take your Glimiprime M 0.5mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimiprime M 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimiprime M 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glimiprime M 0.5mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Glimiprime M 0.5mg/500mg Tablets if these symptoms occur.
Glimiprime M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiprime M 0.5mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimiprime M 0.5mg/500mg tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimiprime M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiprime M 0.5mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimiprime M 0.5mg/500mg ...
40
MRP 46
13% off